A flood-damaged Pfizer joint-venture plant in India that makes injectable chemotherapy may not resume supply until mid-to-late 2028.
Advertisement
Advertisement
Trending on CancerNetwork
1
Evidence Supporting MRD Negativity as a Prognostic and Regulatory Endpoint in Multiple Myeloma
2
CELMoD Mechanisms and Immune Function in Multiple Myeloma
3
T-Cell Fitness and Treatment Sequencing in Multiple Myeloma
4
MRD Negativity and Its Clinical Significance in Multiple Myeloma
5